Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin.
Please provide your email address to receive an email when new articles are posted on . The number of antibacterial agents in clinical and preclinical development decreased from 97 to 90. Of these, 40 ...
Antibiotics currently in the clinical pipeline are still “inefficient” against the increasing prevalence of antimicrobial resistance, according to the World Health Organization’s 2023 report on ...
The PASTEUR Act has been proposed to create a subscription-style model between the federal government and companies that ...
Governments must do more to support the economic case for infectious disease medicines if effective antibiotics are to remain ...
Add Yahoo as a preferred source to see more of our stories on Google. Antimicrobial resistance is outpacing the industry’s efforts to fight it, report finds Industry efforts to combat antimicrobial ...
SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and ...
Morning Overview on MSN
Study finds antibiotic resistance genes can spread through the air
Antibiotic resistance genes, the molecular instructions that allow bacteria to survive drug treatments, are not confined to ...
Industry efforts to combat antimicrobial resistance are failing to keep pace with growing drug-resistant infections, a new report has found. The pipeline of drugs aimed at tackling antimicrobial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results